Mulighed for aendring af ordinationsmønster
Research output: Contribution to journal › Journal article › Research › peer-review
In 2005 the Central Drug Committee in co-operation with the hospitals in the county of Copenhagen (H:S) focused on the increasing use of and expenditure derived from three tumour necrosis factor alpha (TNF-alpha) inhibitors. While the three inhibitors are estimated to be equivalent regarding efficacy and safety, eternacept and adalimumab are twice as expensive as infliximab. With a little effort, the Central Drug Committee succeeded in changing clinicians' prescription pattern in a cost-effective manner.
Udgivelsesdato: 2009-Sep
Udgivelsesdato: 2009-Sep
Translated title of the contribution | Changing clinicians' prescription patterns |
---|---|
Original language | Danish |
Journal | Ugeskrift for læger |
Volume | 171 |
Issue number | 37 |
Pages (from-to) | 2655-6 |
Number of pages | 2 |
ISSN | 0041-5782 |
Publication status | Published - 2009 |
Bibliographical note
Keywords: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Denmark; Drug Costs; Humans; Immunoglobulin G; Physician's Practice Patterns; Practice Guidelines as Topic; Receptors, Tumor Necrosis Factor; Therapeutic Equivalency
ID: 20649539